Medication errors and adverse drug events in pediatric inpatients

R Kaushal1, D W Bates, C Landrigan

  • 1Children's Hospital, Enders 609, Longwood Avenue, Boston, MA 02115, USA.

JAMA
|May 10, 2001
PubMed

Insights

Medication errors are common in pediatric hospital settings, with a high rate of potential adverse drug events (ADEs) compared to adults. Most errors occurred during drug ordering, highlighting the need for improved prevention strategies.

Area of Science:

  • Pediatric pharmacology
  • Patient safety research
  • Epidemiology of iatrogenic injuries

Background:

  • Iatrogenic injuries, including medication errors, pose a significant challenge in hospitalized populations.
  • Limited epidemiological data exist on medication errors specifically within pediatric inpatient settings.

Purpose of the Study:

  • To determine the incidence of medication errors, adverse drug events (ADEs), and potential ADEs in pediatric inpatients.
  • To compare pediatric ADE rates with previously documented adult rates.
  • To identify common types of medication errors and assess the potential effectiveness of prevention strategies.

Main Methods:

  • A prospective cohort study involving 1120 patients across two academic institutions over six weeks.
  • Data collection included clinical staff reports, medication order sheets, administration records, and patient charts.
  • Identification of medication errors, potential ADEs, and ADEs was conducted through rigorous review processes.

Main Results:

  • A total of 616 medication errors (5.7%), 115 potential ADEs (1.1%), and 26 ADEs (0.24%) were identified from 10,778 medication orders.
  • The rate of potential ADEs in pediatric patients was three times higher than in adults, particularly in neonatal intensive care units.
  • Most potential ADEs stemmed from the drug ordering stage, involving incorrect dosing, anti-infective drugs, and intravenous medications.

Conclusions:

  • Medication errors are prevalent in pediatric inpatient environments.
  • The high rate of potential ADEs underscores the urgent need for enhanced safety measures and interventions.
  • Computerized physician order entry and ward-based pharmacists show significant potential in preventing ADEs.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...